InMed Pharmaceuticals is a clinical stage biopharmaceutical company that specializes in developing therapies through the research and development into the extensive pharmacology of cannabinoids coupled with innovative drug delivery systems.
InMed is utilizing its proprietary "Intelligent Cannabinoid Drug Design Platform" to identify new bioactive compounds within the cannabis plant that interact with certain genes responsible for specific diseases. These newly discovered drug candidates are developed from cannabinoids and other botanical sources significantly reduce side effects while optimizing therapeutic benefits. Our proprietary platform technology, product pipeline, and accelerated drug discovery/development pathway are the fundamental value drivers of the Company.
IMLFF Detailed Quote
|Day's Range:||0.46 - 0.52|
|52wk Range:||0.05 - 0.72|
IMLFF Recent Headlines
- INMED PHARMACEUTICALS, INC. Financials 04/19/2017 05:04 PM
- InMed Pharmaceuticals' Unique Approach Featured in Forbes -- CFN Media 03/27/2017 01:00 PM[Marketwired] - CFN Media Group , the leading creative agency and digital media network dedicated to legal cannabis, announces that InMed Pharmaceuticals Inc. , a preclinical biotech company focused on the development ...
- InMed's Exceptional Management Team Executes Ambitious Plan -- CFN Media 03/22/2017 01:00 PM[Marketwired] - CFN Media Group , the leading creative agency and digital media network dedicated to legal cannabis, announces the publication of an article discussing InMed Pharmaceuticals Inc.'s exceptional management ...
- NetworkNewsWire Announces Publication of Discussion on the R&D of Cannabinoids for Medical Use 03/16/2017 12:30 PM[Marketwired] - NetworkNewsWire , a multifaceted financial news and publishing company, today announces the publication of an editorial featuring InMed Pharmaceuticals , an NNW client that specializes in developing novel ...
- InMed Pharmaceuticals to Present at the 29th Annual ROTH Conference 03/08/2017 01:00 PM[Accesswire] - VANCOUVER, BC / ACCESSWIRE / March 8, 2017 / InMed Pharmaceuticals, Inc. ("InMed") (CSE: IN; OTCQB: IMLFF) announces today that Eric A. Adams, Chief Executive Officer, will be presenting to U.S. ...